Quinapril 5mg Tablets

Manufacturer SOLCO Active Ingredient Quinapril(KWIN a pril) Pronunciation KWIN-a-pril
WARNING: Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away. @ COMMON USES: It is used to treat high blood pressure.It is used to treat heart failure (weak heart).It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antihypertensive
đŸ§Ŧ
Pharmacologic Class
Angiotensin-converting enzyme (ACE) inhibitor
🤰
Pregnancy Category
Not applicable (Contraindicated in 2nd/3rd trimester)
✅
FDA Approved
Dec 1991
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Quinapril is a medication used to treat high blood pressure (hypertension) and heart failure. It belongs to a class of drugs called ACE inhibitors. It works by relaxing blood vessels, which helps lower blood pressure and makes it easier for your heart to pump blood.
📋

How to Use This Medicine

Taking Your Medication

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely. You can take this medication with or without food, and it's best to take it at the same time every day. Continue taking your medication as directed by your doctor or healthcare provider, even if you're feeling well.

It's also important to stay hydrated by drinking plenty of non-caffeinated liquids, unless your doctor advises you to limit your fluid intake.

Storing and Disposing of Your Medication

To keep your medication effective and safe, store it at room temperature, protected from light and moisture. Avoid storing it in a bathroom, and keep it out of reach of children and pets. When you're finished with your medication or it's expired, dispose of it properly. Do not flush it down the toilet or pour it down the drain unless instructed to do so by your doctor or pharmacist. If you're unsure about how to dispose of your medication, ask your pharmacist for guidance. You may also want to check if there are any drug take-back programs in your area.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for a missed one.
💡

Lifestyle & Tips

  • Continue to follow a low-sodium diet as recommended by your doctor.
  • Engage in regular physical activity.
  • Limit alcohol intake.
  • Avoid potassium-rich salt substitutes unless advised by your doctor.
  • Monitor your blood pressure regularly at home if advised.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: 10-20 mg once daily, adjusted based on response
Dose Range: 5 - 80 mg

Condition-Specific Dosing:

Hypertension (initial): 10-20 mg once daily. For patients on diuretics, initial dose 5 mg once daily.
Heart Failure (initial): 5 mg twice daily, titrated up to 20-40 mg daily in two divided doses.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established (limited data, generally not recommended)
Adolescent: Not established (limited data, generally not recommended)
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: CrCl > 60 mL/min: No adjustment needed.
Moderate: CrCl 30-60 mL/min: Initial dose 5 mg once daily. Max 40 mg/day.
Severe: CrCl 10-30 mL/min: Initial dose 2.5 mg once daily. Max 20 mg/day.
Dialysis: CrCl < 10 mL/min: Initial dose 2.5 mg once daily. Quinaprilat is dialyzable, administer after dialysis.

Hepatic Impairment:

Mild: No specific adjustment, but use with caution.
Moderate: No specific adjustment, but use with caution.
Severe: Not available (use with extreme caution, monitor closely)

Pharmacology

đŸ”Ŧ

Mechanism of Action

Quinapril is a prodrug that is hydrolyzed to quinaprilat, its active metabolite. Quinaprilat is an angiotensin-converting enzyme (ACE) inhibitor. It prevents the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor and stimulator of aldosterone secretion. This leads to decreased systemic vascular resistance, reduced aldosterone secretion (resulting in decreased sodium and water retention), and increased bradykinin levels (contributing to vasodilation). These effects result in a reduction in blood pressure.
📊

Pharmacokinetics

Absorption:

Bioavailability: Approximately 60% (for quinaprilat after quinapril administration)
Tmax: Quinapril: 1 hour; Quinaprilat: 1-2 hours
FoodEffect: Food may delay absorption but does not significantly affect the extent of absorption.

Distribution:

Vd: Not available (Quinaprilat: approximately 100 L)
ProteinBinding: Quinapril: ~97%; Quinaprilat: ~97%
CnssPenetration: Limited

Elimination:

HalfLife: Quinapril: ~1 hour; Quinaprilat: ~2 hours (terminal elimination half-life), effective accumulation half-life ~10 hours
Clearance: Quinaprilat: Renal clearance is approximately 220 mL/min
ExcretionRoute: Renal (primarily as quinaprilat and other inactive metabolites), Fecal (minor)
Unchanged: Less than 5% (quinapril); ~60% (quinaprilat via urine)
âąī¸

Pharmacodynamics

OnsetOfAction: Within 1 hour
PeakEffect: 2-4 hours
DurationOfAction: 24 hours (for blood pressure lowering effect)

Safety & Warnings

âš ī¸

BLACK BOX WARNING

When pregnancy is detected, discontinue Quinapril as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.
âš ī¸

Side Effects

Serious Side Effects: Seek Medical Attention Immediately

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical help right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of kidney problems, including:
+ Inability to pass urine
+ Changes in urine output
+ Blood in the urine
+ Sudden weight gain
Signs of high potassium levels, such as:
+ Abnormal heartbeat
+ Confusion
+ Weakness, lightheadedness, or dizziness
+ Feeling like passing out
+ Numbness or tingling
+ Shortness of breath
Severe dizziness or fainting
Persistent cough
Severe stomach pain
Severe nausea or vomiting
Liver problems, which may be indicated by:
+ Dark urine
+ Fatigue
+ Decreased appetite
+ Stomach pain or upset
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes (jaundice)
Signs of infection, such as:
+ Fever
+ Chills
+ Sore throat

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other unusual symptoms, contact your doctor or seek medical help:

Cough
* Dizziness

Reporting Side Effects

This list is not exhaustive, and you may experience other side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Swelling of the face, lips, tongue, or throat (angioedema) - seek emergency medical attention immediately.
  • Difficulty breathing or swallowing.
  • Severe dizziness or fainting.
  • Yellowing of the skin or eyes (jaundice).
  • Signs of high potassium (muscle weakness, slow or irregular heartbeat).
  • Persistent dry cough that is bothersome.
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have a history of angioedema, a severe and potentially life-threatening reaction characterized by swelling of the hands, face, lips, eyes, tongue, or throat, difficulty breathing, swallowing problems, or unusual hoarseness.
If you are undergoing any of the following medical treatments: apheresis, dialysis, or hemofiltration.
If you are currently taking any of the following medications: Aliskiren, azilsartan, candesartan, eprosartan, irbesartan, losartan, olmesartan, telmisartan, or valsartan.
* If you have taken a medication containing sacubitril within the last 36 hours.

Please note that this is not an exhaustive list of all potential interactions. It is crucial to discuss all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, as well as any health problems, with your doctor and pharmacist. This will help ensure your safety while taking this medication. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

Important Information to Share with Your Healthcare Team

Inform all of your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Precautions to Ensure Your Safety

To avoid accidents, do not drive or perform tasks that require alertness until you know how this medication affects you. When getting up from a sitting or lying down position, rise slowly to minimize the risk of dizziness or fainting. Be cautious when climbing stairs.

Monitoring Your Health

Follow your doctor's instructions for checking your blood pressure regularly. Additionally, have your blood work checked as directed by your doctor and discuss the results with them.

Interactions with Other Substances

If you are taking a salt substitute containing potassium, a potassium-sparing diuretic, or a potassium product, consult with your doctor. Similarly, if you are on a low-salt or salt-free diet, discuss this with your doctor.

Special Considerations

If you have high blood pressure and are taking this medication, talk to your doctor before using over-the-counter (OTC) products that may increase blood pressure, such as cough or cold medications, diet pills, stimulants, non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, and certain natural products or aids. Also, consult with your doctor before consuming alcohol.

Staying Safe in Various Situations

In hot weather or during physical activity, be cautious and drink plenty of fluids to prevent dehydration. If you experience excessive sweating, fluid loss, vomiting, or diarrhea, inform your doctor, as these conditions may lead to low blood pressure.

Effectiveness and Potential Risks

It is essential to note that this medication may be less effective in lowering blood pressure in Black patients. In some cases, another medication may be prescribed in conjunction with this one. If you have any questions or concerns, discuss them with your doctor.

Rare but Serious Reaction

A severe and potentially life-threatening reaction called angioedema has been reported. The risk of angioedema may be higher in Black patients.

Breastfeeding

If you are breastfeeding, inform your doctor, as you will need to discuss any potential risks to your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Severe hypotension (low blood pressure)
  • Dizziness
  • Lightheadedness
  • Tachycardia (rapid heart rate)
  • Bradycardia (slow heart rate)
  • Renal failure

What to Do:

Call 911 or your local poison control center (e.g., 1-800-222-1222 in the US) immediately. Treatment is supportive, including intravenous fluids to restore blood pressure. Quinaprilat can be removed by hemodialysis.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Aliskiren (in patients with diabetes or renal impairment)
  • Sacubitril/valsartan (Entresto) - concomitant use or within 36 hours of last dose of ACE inhibitor
🔴

Major Interactions

  • Potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride) - increased risk of hyperkalemia
  • Potassium supplements - increased risk of hyperkalemia
  • NSAIDs (Nonsteroidal Anti-inflammatory Drugs) - may reduce antihypertensive effect and increase risk of renal impairment
  • Lithium - increased serum lithium levels and toxicity
  • mTOR inhibitors (e.g., sirolimus, everolimus, temsirolimus) - increased risk of angioedema
  • Neprilysin inhibitors (e.g., sacubitril) - increased risk of angioedema
🟡

Moderate Interactions

  • Diuretics (thiazide, loop) - increased risk of symptomatic hypotension (especially first-dose)
  • Other antihypertensives - additive hypotensive effects
  • Insulin and oral hypoglycemics - increased risk of hypoglycemia
  • Gold (sodium aurothiomalate) - nitritoid reactions (facial flushing, nausea, vomiting, hypotension) reported rarely
đŸŸĸ

Minor Interactions

  • Antacids - may reduce bioavailability (separate administration by 2 hours)

Monitoring

đŸ”Ŧ

Baseline Monitoring

Blood Pressure (BP)

Rationale: To establish baseline and guide initial dosing.

Timing: Prior to initiation

Serum Creatinine (Cr) and Blood Urea Nitrogen (BUN)

Rationale: To assess renal function, as quinapril is renally eliminated and can affect renal perfusion.

Timing: Prior to initiation

Serum Potassium (K+)

Rationale: To assess baseline potassium levels, as ACE inhibitors can cause hyperkalemia.

Timing: Prior to initiation

📊

Routine Monitoring

Blood Pressure (BP)

Frequency: Regularly, especially after dose adjustments, then periodically (e.g., monthly, quarterly)

Target: <130/80 mmHg or individualized target

Action Threshold: If BP remains elevated or symptomatic hypotension occurs, adjust dose or consider alternative therapy.

Serum Creatinine (Cr) and BUN

Frequency: Within 1-2 weeks of initiation or dose increase, then periodically (e.g., every 3-6 months) or as clinically indicated.

Target: Stable or within acceptable limits (e.g., <30% increase from baseline)

Action Threshold: Significant increase (>30% from baseline or progressive increase) may indicate renal impairment; consider dose reduction or discontinuation.

Serum Potassium (K+)

Frequency: Within 1-2 weeks of initiation or dose increase, then periodically (e.g., every 3-6 months) or as clinically indicated, especially in patients with renal impairment or on potassium-sparing diuretics.

Target: 3.5-5.0 mEq/L

Action Threshold: K+ > 5.5 mEq/L may require dose reduction, discontinuation, or management of hyperkalemia.

đŸ‘ī¸

Symptom Monitoring

  • Angioedema (swelling of face, lips, tongue, throat, extremities)
  • Persistent dry cough
  • Dizziness or lightheadedness (especially with first dose or dose increase)
  • Signs of hyperkalemia (muscle weakness, fatigue, irregular heartbeat)
  • Signs of infection (fever, sore throat) due to rare neutropenia

Special Patient Groups

🤰

Pregnancy

Contraindicated during the second and third trimesters of pregnancy due to significant risk of fetal injury and death. Discontinue as soon as pregnancy is detected. Use in the first trimester is generally avoided due to potential risks.

Trimester-Specific Risks:

First Trimester: Potential for major congenital malformations (though less established than 2nd/3rd trimester risks). Generally avoided.
Second Trimester: Significant risk of fetal renal dysfunction, oligohydramnios, fetal lung hypoplasia, skeletal deformations, and death.
Third Trimester: Significant risk of fetal renal dysfunction, oligohydramnios, fetal lung hypoplasia, skeletal deformations, and death.
🤱

Lactation

Quinapril and its active metabolite quinaprilat are excreted in human milk in small amounts. Generally considered low risk for healthy, full-term infants, but caution is advised, especially for preterm or ill infants. Monitor infant for adverse effects.

Infant Risk: Low to moderate risk (L3)
đŸ‘ļ

Pediatric Use

Safety and effectiveness have not been established in pediatric patients. Use is generally not recommended.

👴

Geriatric Use

No overall differences in effectiveness or safety have been observed between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Start with lower doses (e.g., 5 mg) and titrate slowly, especially in those with impaired renal function.

Clinical Information

💎

Clinical Pearls

  • Quinapril is a prodrug that is converted to its active form, quinaprilat, in the liver.
  • A common side effect of ACE inhibitors, including quinapril, is a persistent dry cough, which typically resolves upon discontinuation.
  • Angioedema (swelling of the face, lips, tongue, or throat) is a rare but potentially life-threatening side effect that can occur at any time during treatment.
  • First-dose hypotension can occur, especially in patients who are volume-depleted (e.g., on diuretics, salt-restricted diet). Consider discontinuing diuretics 2-3 days prior to initiation if possible, or start with a lower dose (5 mg).
  • Monitor serum potassium levels, especially in patients with renal impairment, diabetes, or those taking potassium-sparing diuretics or supplements, due to the risk of hyperkalemia.
  • Avoid concomitant use with sacubitril/valsartan due to increased risk of angioedema; a 36-hour washout period is required between these drugs.
🔄

Alternative Therapies

  • Other ACE inhibitors (e.g., lisinopril, enalapril, ramipril)
  • Angiotensin Receptor Blockers (ARBs) (e.g., losartan, valsartan, candesartan)
  • Calcium Channel Blockers (CCBs) (e.g., amlodipine, nifedipine)
  • Thiazide diuretics (e.g., hydrochlorothiazide, chlorthalidone)
  • Beta-blockers (e.g., metoprolol, carvedilol)
💰

Cost & Coverage

Average Cost: Varies widely, typically $10-$50 per 30 tablets
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (Generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor for further evaluation and guidance. To ensure safe and effective treatment, never share your medication with others or take someone else's medication. Some medications may have additional patient information leaflets, so it is a good idea to consult with your pharmacist for more information. If you have any questions or concerns about your medication, do not hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the overdose, be prepared to provide details about the medication taken, the amount, and the time it occurred.